News

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing “gray” market for purchasing active ...
DIY tirzepatide, internet detective work and insurance appeals: The lengths 3 people are going to for weight loss drugs. Natalie Rahhal. July 2, 2025 at 7:00 AM. Copied; ...
DIY tirzepatide, internet detective work and insurance appeals: The lengths 3 people are going to for weight loss drugs "Not being on it is not an option." Natalie Rahhal, Reporter.
Tirzepatide was first approved for use in the US in May 2022, when it received an indication for adult patients with type 2 diabetes. 1 Indications for chronic weight management and sleep apnea ...
DIY tirzepatide, internet detective work and insurance appeals: The lengths 3 people are going to for weight loss drugs. Story by Natalie Rahhal • 27m.
Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both ...
The researchers reported that tirzepatide (0% to 40.6%) and semaglutide 2.4 mg (0% to 32.2%) increased significantly among adults without diabetes with any or incident use of WLMs, though ...
The active ingredient in the drug, tirzepatide, has already been approved for the treatment of Type 2 diabetes under the name Mounjaro since May 2022. But the FDA's new approval means adults who ...
The Food and Drug Administration approved Eli Lilly's tirzepatide drug for weight loss, paving the way for even wider use of the blockbuster medication. The active ingredient in the drug ...